Facilitators of and obstacles to consultation in patients with advanced basal cell carcinoma: a French pilot study.


Journal

Archives of dermatological research
ISSN: 1432-069X
Titre abrégé: Arch Dermatol Res
Pays: Germany
ID NLM: 8000462

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 30 08 2020
accepted: 07 12 2020
revised: 09 11 2020
pubmed: 13 1 2021
medline: 8 2 2022
entrez: 12 1 2021
Statut: ppublish

Résumé

Basal cell carcinoma is the most common skin cancer for which surgery is usually the unique and definitive treatment. Advanced basal cell carcinoma is not eligible to surgery when underlying structures are destroyed. Delayed consultation is the principal cause of advanced basal cell carcinoma. It is questionable why some patients seek care only when the tumour is advanced. The objective of this study was to identify the psychosocial factors involved in delayed consultation. We used a qualitative approach, conducting semi-structured interviews with advanced basal cell carcinoma patients and the healthcare staff of a dermatology unit to explore why some patients consult only when basal cell carcinoma is advanced. We then put our findings into perspective and created a logical model for change. We interviewed 14 patients and 12 healthcare staff. The first lesion was associated with banalization. Then, denial and fear of diagnosis or treatment were post common. Finally, the advanced basal cell carcinoma's symptoms, along with social pressure, created the intention to seek medical help and improved disease awareness. We developed a logical model that summarizes these findings. In this pilot study, we modelled factors that delayed consultation. This will aid future research and targeted interventions reducing delay, in particular by improving knowledge and by using social pressure as facilitators. Trial registration: NCT04124796.

Identifiants

pubmed: 33433714
doi: 10.1007/s00403-020-02175-x
pii: 10.1007/s00403-020-02175-x
doi:

Banques de données

ClinicalTrials.gov
['NCT04124796']

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

829-835

Subventions

Organisme : Société Française de Dermatologie et de Pathologie Sexuellement Transmissible
ID : 2017
Organisme : Ligue Contre le Cancer
ID : 2017

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.

Références

Lomas A, Leonardi-Bee J, Bath-Hextall F (2012) A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 166:1069–1080
doi: 10.1111/j.1365-2133.2012.10830.x
Jacobsen AA, Aldahan AS, Hughes OB, Shah VV, Strasswimmer J (2016) Hedgehog pathway inhibitor therapy for locally advanced and metastatic basal cell carcinoma: a systematic review and pooled analysis of interventional studies. JAMA Dermatol 152:816–824
doi: 10.1001/jamadermatol.2016.0780
Safer MA, Tharps QJ, Jackson TC, Leventhal H (1979) Determinants of three stages of delay in seeking care at a medical clinic. Med Care 17:11–29
doi: 10.1097/00005650-197901000-00002
de Vries H (2017) An integrated approach for understanding health behavior; the I-change model as an example. PBSI J 2:1–8
Chojnacka-Szawłowska G, Kościelak R, Karasiewicz K, Majkowicz M, Kozaka J (2013) Delays in seeking cancer diagnosis in relation to beliefs about the curability of cancer in patients with different disease locations. Psychol Health 28:154–170
doi: 10.1080/08870446.2012.700056
Alam M, Goldberg LH, Silapunt S et al (2011) Delayed treatment and continued growth of nonmelanoma skin cancer. J Am Acad Dermatol 64:839–848
doi: 10.1016/j.jaad.2010.06.028
Renzi C, Mastroeni S, Mannooranparampil TJ, Passarelli F, Pasquini P (2011) Timely diagnosis of cutaneous squamous cell carcinoma: The GP’s role. Fam Pract 28:277–279
doi: 10.1093/fampra/cmq103
Yancovitz M, Rizzo C, Julian P, Oliveria SA, Becker D (2013) Patient perceptions of nonmelanoma skin cancer before diagnosis. Dermatol Surg 39:1496–1501
pubmed: 24090260
Kakagia D, Trypsiannis G, Karanikas M, Mitrakas A, Lyratzopoulos N, Polychronidis A (2013) Patient-related delay in presentation for cutaneous squamous cell carcinoma a cross-sectional clinical study. Onkologie 36:738–744
pubmed: 24356565
Ristvedt SL, Trinkaus KM (2005) Psychological factors related to delay in consultation for cancer symptoms. Psycho-Oncology 14:339–350
doi: 10.1002/pon.850
Husein-ElAhmed H, Gutierrez-Salmeron MT, Naranjo-Sintes R, Aneiros-Cachaza J (2013) Factors related to delay in the diagnosis of basal cell carcinoma. J Cutan Med Surg 17:27–32
doi: 10.2310/7750.2012.12030
Spring B (2007) Evidence-based practice in clinical psychology: What it is, why it matters; what you need to know. J Clin Psychol 63:611–631
doi: 10.1002/jclp.20373
Amici JM, Battistella M, Beylot-Barry M et al (2015) Defining and recognising locally advanced basal cell carcinoma. Eur J Dermatol 25:586–594
doi: 10.1684/ejd.2015.2641
Prochaska JO, Di Clemente CC (1997) Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 51:390–395
doi: 10.1037/0022-006X.51.3.390
Robinson JK, Altman JS, Rademaker AW (1995) Socioeconomic status and attitudes of 51 patients with giant basal and squamous cell carcinoma and paired controls. Arch Dermatol 131:428–431
doi: 10.1001/archderm.1995.01690160056008
Smith LK, Pope C, Botha JL (2005) Patients’ help-seeking experiences and delay in cancer presentation: a qualitative synthesis. Lancet 366:825–831
doi: 10.1016/S0140-6736(05)67030-4
Sparsa A, Doffoel-Hantz V, Durox H et al (2012) Tumeur maligne historique: 27 case. Ann Dermatol Vener 139:189–193
doi: 10.1016/j.annder.2011.11.009
Körner A, Garland R, Czajkowska Z, Coroiu A, Khanna M (2016) Supportive care needs and distress in patients with non-melanoma skin cancer: Nothing to worry about? Eur J Oncol Nurs 20:150–155
doi: 10.1016/j.ejon.2015.07.006
Radiotis G, Roberts N, Czajkowska Z, Khanna M, Körner A (2014) Nonmelanoma skin cancer: disease-specific quality-of-life concerns and distress. Oncol Nurs Forum 41:57–65
doi: 10.1188/14.ONF.57-65
Henderson JG (2006) Denial and repression as factors in the delay of patients with cancer presenting themselves to the physician. Ann NY Acad Sci 125:856–864
doi: 10.1111/j.1749-6632.1966.tb45436.x
Kannan VD, Veazie PJ (2014) Predictors of avoiding medical care and reasons for avoidance behavior. Med Care 52:336–345
doi: 10.1097/MLR.0000000000000100
Zehou O, Valeyrie-Allanore L, Ortonne N et al (2012) Tumeurs « historiques »: tumeurs négligées trois observations. Ann Dermatol Venereol 139:194–198
doi: 10.1016/j.annder.2011.12.020
Reader TW, Gillespie A (2013) Patient neglect in healthcare institutions: a systematic review and conceptual model. BMC Health Serv Res 13:156–171
doi: 10.1186/1472-6963-13-156
Kasparian NA, McLoone JK, Meiser B (2009) Skin cancer-related prevention and screening behaviors: a review of the literature. J Behav Med 32:406–428
doi: 10.1007/s10865-009-9219-2
Blackford S, Roberts D, Salek MS, Finlay A (1996) Basal cell carcinomas cause little handicap. Qual Life Res 5:191–194
doi: 10.1007/BF00434740

Auteurs

Constance Garrouteigt (C)

Department of Dermatology, University Hospital of Bordeaux, 1, rue Jean Burguet, 33000, Bordeaux, France.

Guillaume Broc (G)

Paul Valéry Montpellier 3, University of Montpellier, EPSYLON EA 4556, Montpellier, France.

Adeline Legrand (A)

Department of Dermatology, University Hospital of Bordeaux, 1, rue Jean Burguet, 33000, Bordeaux, France.

Bruno Quintard (B)

INSERM UMR 1219, Bordeaux Population Health Research Center, Team: Handicap, Activity, Cognition, Health, University of Bordeaux, Bordeaux, France.

Marie Beylot-Barry (M)

Department of Dermatology, University Hospital of Bordeaux, 1, rue Jean Burguet, 33000, Bordeaux, France. marie.beylot-barry@chu-bordeaux.fr.
INSERM U1053, UMR Bariton, Oncogenesis of Cutaneous Lymphoma, University of Bordeaux, Bordeaux, France. marie.beylot-barry@chu-bordeaux.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH